Abstract
The European Academy of Otology and Neurotology in collaboration with the Japanese Otological Society (EAONO/JOS) recently produced a joint consensus document outlining the definitions, classification and staging of middle ear cholesteatoma. The goals were to provide terminologies in the description of cholesteatoma, classify cholesteatoma into distinct categories to facilitate the comparison of surgical outcomes and to provide a staging system that reflects the severity, difficulty of complete removal and restoration of normal function. Cholesteatoma is considered a benign, expanding and destructive epithelial lesion of the temporal bone that is the result of a multifactorial process. If undetected and left treated, cholesteatoma may lead to significant complications including hearing loss, temporal bone destruction and cranial invasion. Recent advances in imaging modalities have allowed for high sensitivity and specificity in identifying the presence of cholesteatoma. Despite these advances, deficiencies exist around the world with access to health care facilities meaning cholesteatoma remains a serious and challenging entity to manage whether found within the pediatric or adult population. Proper diagnosis and management of each form of cholesteatoma is achieved by a thorough understanding of the etiology, classification, clinical presentation and histology, thereby facilitating prevention, early detection and appropriate treatment.
Similar content being viewed by others
References
Yung M, Tono T, Olszewska E, et al. EAONO/JOS Joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol. 2017;13:1–8.
Müller J. Ueber den feineren bau und die formen der krankhaften geschwulste. Berlin, G Reimer. 1838. Folio.
De Verney JG. Traité de l’organie de l’ouïe. Paris: E. Michallet; 1683.
Aquino JE, Cruz Filho NA, de Aquino JN. Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases. Braz J Otorhinolaryngol. 2011;77:341–7.
Bennett M, Warren F, Jackson GC. Congenital cholesteatoma: theories, facts and 53 patients. Otolaryngol Clin N Am. 2006;39:1081–94.
Shohet JA, De Jong AI. The management of pediatric cholesteatoms. Otolaryngol Clin N Am. 2002;35:841–51.
Olszewska E, Wagner M, Bernal-Sprekelsen M, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol. 2004;261:6–24.
Barath K, Huber AM, Stampfil P, et al. Neuroradiology of cholesteatomas. AJNR Am J Neuroradiol. 2011;32:221–9.
Jennings BA, Prinsley P, Philpott C, et al. The genetics of cholesteatoma. A systematic review using narrative synthesis. Clin Otolaryngol. 2017;43:55–67.
Bois E, Nassar M, Zenaty D, et al. Otologic disorders in Turner syndrome. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;135:21–4.
Lim DBN, Gault EJ, Kubba H, et al. Cholesteatoma has a high prevalence in Turner syndrome, highlighting the need for earlier diagnosis and the potential benefits of otoscopy training for paediatricians. Acta Paediatr. 2014;103:e282–7.
Hall JE, Richter GT, Choo DI. Surgical management of otologic disease in pediatric patients with Turner syndrome. Int J Pediatr Otorhinolaryngol. 2009;73:57–65.
Mann W, Al-Nawas B, Wriedt S. Cholesteatoma of the hypotympanum in a patient with Treacher Collins syndrome. Auris Nasus Larynx. 2014;41:101–4.
Nash R, Possamai V, Maskell S, et al. Canal wall reconstruction and preservation in the surgical management of cholesteatoma in children with Down’s syndrome. Int J Pediatr Otorhinolaryngol. 2014;78:1747–51.
Paulson LM, Weaver TS, Macarthur CJ. Outcomes of tympanostomy tube placement in children with Down syndrome—a retrospective review. Int J Pediatr Otorhinolaryngol. 2014;78:223–6.
Bacciu A, Pasanisi E, Vincenti V, et al. Surgical treatment of middle ear cholesteatoma in children with Down syndrome. Otol Neurotol. 2005;26:1007–10.
Suzuki C, Ohtani I. Bone destruction resulting from rupture of a cholesteatoma sac: temporal bone pathology. Otol Neurotol. 2004;25:674–7.
Büchner SA, Itin P. Focal dermal hypoplasia syndrome in a male patient. Report of a case and histologic and immunohistochemical studies. Arch Dermatol. 1992;128:1078–82.
Imbery TE, Sobin LB, Commesso E, et al. Long-term otologic and audiometric outcomes in patients with cleft palate. Otolaryngol Head Neck Surg. 2017;157:676–82.
Kopcsányi G, Vincze O, Bagdán V, et al. Retrospective analysis of tympanoplasty in children with cleft palate: a 24-year experience. II. Cholesteatomatous cases. Int J Pediatr Otorhinolaryngol. 2015;79:698–706.
Djurhuus BD, Skytthe A, Faber CE, Christensen K. Cholesteatoma risk in 8,593 orofacial cleft cases and 6,989 siblings: a nationwide study. Laryngoscope 2015;125:1225–9.
Lau CC, Loh KK, Kunaratnam N. Middle ear diseases in cleft palate patients in Singapore. Ann Acad Med Singap. 1988;17:372–4.
Kuo CL, Lien CF, Chu CH, et al. Otitis media with effusion in children with cleft lip and palate: a narrative review. Int J Pediatr Otorhinolaryngol. 2013;77:1403–9.
James AL, Papsin BC. Some considerations in congenital cholesteatoma. Curr Opin Otolaryngol Head Neck Surg. 2013;21:431–9.
Harris L, Cushing SL, Hubbard B, et al. Impact of cleft palate type on the incidence of acquired cholesteatoma. Int J Pediatr Otorhinolaryngol. 2013;77:695–8.
Kuo CL, Shiao AS, Wen HC, et al. Increased risk of cholesteatoma among patients with allergic rhinitis: a nationwide investigation. Laryngoscope 2017;128:547–53.
Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:1–17.
Michaels L. Origin of congenital cholesteatoma from a normally occurring epidermoid rest in the developing middle ear. Int J Pediatr Otorhinolaryngol. 1988;15:51–65.
Levenson MJ, Michaels L, Parisier SC, et al. Congenital cholesteatomas in children: an embryologic correlation. Laryngoscope 1988;98:949–55.
Aimi K. Role of the tympanic ring in the pathogenesis of congenital cholesteatoma. Laryngoscope 1983;93:1140–6.
Tos M. A new pathogenesis of mesotympanic (congenital) cholesteatoma. Laryngoscope 2000;110:1890–7.
Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope 2015;125:234–40.
Sudhoff H, Tos M. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory. Am J Otol. 2000;21:786–92.
Karmody CS, Northrop C. The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis. Otol Neurotol. 2012;33:42–7.
Falcioni M, Taibah A, Rohit. Pulsatile tinnitus as a rare presenting symptom of residual cholesteatoma. J Laryngol Otol. 2004;118:165–6.
Ahn JM, Huang CC, Abramson M. Localization of interleukin-1 in human cholesteatoma. Am J Otolaryngol. 1990;11:71–7.
Venail F, Bonafe A, Poirrier V, et al. Comparison of echo-planar diffusion-weighted imaging and delayed postcontrast T1-weighted MR imaging for the detection of residual cholesteatoma. AJNR Am J Neuroradiol. 2008;29:1363–8.
Corrales CE, Blevins NH. Imaging for evaluation of cholesteatoma: current concepts and future directions. Curr Opin Otolaryngol Head Neck Surg. 2013;21:461–7.
Henninger B, Kremser C. Diffusion weighted imaging for the detection and evaluation of cholesteatoma. World J Radiol. 2017;28:217–22.
Vercruysse JP, De Foer B, Pouillon M, et al. The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients. Eur Radiol. 2006;16:1461–7.
Más-Estellés F, Mateos-Fernández M, Carrascosa-Bisquert B, et al. Contemporary non-echo-planar diffusion-weighted imaging of middle ear cholesteatomas. Radiographics. 2012;32:1197–213.
Caponetti G, Thompson LD, Pantanowitz L. Cholesteatoma. Ear Nose Throat J. 2009;88:1196–8.
Bassiouny M, Badour N, Omran A, et al. Histopathological and immunohistochemical characteristics of acquired cholesteatoma in children and adults. EJENTAS 2012;13:7–12.
Rothschild S, Ciernik IF, Hartmann M, et al. Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. Am J Otolaryngol. 2009;30:256–60.
Hamed MA, Nakata S, Shiogama K, et al. Cytokeratin 13, Cytokeratin 17, and Ki-67 expression in human acquired cholesteatoma and their correlation with its destructive capacity. Clin Exp Otorhinolaryngol. 2017;10:213–20.
Chole RA, Tinling SP. Basal lamina breaks in the histogenesis of cholesteatoma. Laryngoscope 1985;95:270–5.
Ferlito O, Devaney KO, Rinaldo A, et al. Clinicopathological consultation ear cholesteatoma versus cholesterol granuloma. Ann Otol Rhinol Laryngol. 1997;106:79–85.
Preciado DA. Biology of cholesteatoma: special considerations in pediatric patients. Int J Pediatr Otorhinolaryngol. 2012;76:319–21.
Maniu A, Harabagiu O, Perde Schrepler M, et al. Molecular biology of cholesteatoma. Rom J Morphol Embryol. 2014;55:7–13.
Sudhoff H, Dazert S, Gonzales AM, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol. 2000;21:793–8.
Fukudome S, Wang C, Hamajima Y, et al. Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor. JAMA Otolaryngol Head Neck Surg. 2013;139:273–8.
Haruyama T, Furukawa M, Kusunoki T, et al. Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma. J Otorhinolaryngol Relat Spec. 2010;72:325–31.
Olszewska E, Matulka M, Mroczko B, et al. Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma. Histol Histopathol. 2016;31:307–15.
Chen AP, Wang B, Zhong F, et al. Expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin are associated with middle ear cholesteatoma risk. Acta Otolaryngol. 2015;135:655–66.
Kuo CL, Liao WH, Shiao, AS. A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol. 2015;272:3601–9.
Morita Y, Takahashi K, Izumi S, et al. Risk factors of recurrence in pediatric congenital cholesteatoma. Otol Neurotol. 2017;38:1463–9.
Vital V. Pediatric cholesteatoma: personal experience and review of the literature. Otorhinolaryngol Head Neck Surg. 2011;45:5–14.
Zhang H, Wong PY, Magos T, et al. Use of narrow band imaging and 4K technology in otology and neuro-otology: preliminary experience and feasibility study. Eur Arch Otorhinolaryngol. 2017;275:301–5.
Tomlin J, Chang D, McCutcheon B, et al. Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol. 2013;18:135–42.
Acknowledgements
Thanks and gratitude to Dr. Robert Shih for his tremendous assistance in radiographic image selection and interpretation and to Drs. Caroline Schlocker and George Conley for their intraoperative images and interpretation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
James T. Castle declares that he has no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Disclaimer: The opinions and assertions expressed herein are those of the authors and are not to be construed as official or representing the views of the Department of the Navy or the Department of Defense. I certify that all individuals who qualify as authors have been listed; each has participated in the conception and design of this work, the writing of the document, and the approval of the submission of this version; that the document represents valid work; that if we used information derived from another source, we obtained all necessary approvals to use it and made appropriate acknowledgements in the document; and that each takes public responsibility for it.
Rights and permissions
About this article
Cite this article
Castle, J.T. Cholesteatoma Pearls: Practical Points and Update. Head and Neck Pathol 12, 419–429 (2018). https://doi.org/10.1007/s12105-018-0915-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-018-0915-5